Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-6 of 6 for Cirrhosis

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  2. Transforming Non-Invasive Liver Disease Detection by MRE: The Hepatogram

    Rochester, MN

  3. Circulating Nucleic Acid Based Biomarkers for Early Detection of Hepatocellular Carcinoma (HCC)

    Jacksonville, FL

  4. A Study to Evaluate Cardiopulmonary Exercise Testing in Liver Transplant Candidates

    Scottsdale/Phoenix, AZ

  5. A Study to Assess Multiparametric MR Elastography (MRE) in Diagnosing and Monitoring Cirrhosis or Hepatocellular Carcinoma (HCC) Patients

    Rochester, MN

  6. A Study of Infections and Other Complications of Patients Hospitalized with Liver Cirrhosis

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer